Systemic therapy for locally advanced and metastatic non-small cell lung cancer: A review Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Brain Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Gene Rearrangement
  • Lung Neoplasms
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyridines
  • Receptor Protein-Tyrosine Kinases

abstract

  • Improved understanding of the biology and molecular subtypes of non-small cell lung cancer have led to more biomarker-directed therapies for patients with metastatic disease. These biomarker-directed therapies and newer empirical treatment regimens have improved overall survival for patients with metastatic non-small cell lung cancer.

publication date

  • August 27, 2019

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/jama.2019.11058

PubMed ID

  • 31454018

Additional Document Info

start page

  • 764

end page

  • 774

volume

  • 322

number

  • 8